{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-405580","form_type":"8-K","ticker":"VKTX","cik":"0001607678","company_name":"Viking Therapeutics, Inc.","filed_at":"2026-09-28T21:27:17+00:00","discovered_at":"2026-09-28T21:28:46.166429+00:00","generated_at":"2026-10-12T13:38:39.130566+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Viking Therapeutics raises ~$548M via stock and 2.00% convertible notes offerings","bullets":["Equity offering: 7,857,143 shares sold at $35.00/share, plus full exercise of the 1,178,571-share underwriter option; net proceeds ~$297.0M; closed Sept. 25, 2026.","Debt offering: $225M of 2.00% convertible senior notes due Oct. 15, 2032, plus $33.75M option exercised in full; net proceeds ~$250.8M; interest payable semi-annually from April 15, 2027.","Notes convert initially at ~$50.75/share (19.7044 shares per $1,000), a 45% premium to the $35.00 equity offering price; U.S. Bank Trust Company is trustee.","Proceeds earmarked for clinical development and commercialization of VK2735, development of VK3019, and general R&D, working capital and corporate purposes.","Notes callable on or after Oct. 22, 2029 if the stock exceeds 130% of the conversion price; cleanup redemption permitted if less than 15% of principal remains outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-405580","json":"https://secwatch.observer/filing/0001193125-26-405580.json","markdown":"https://secwatch.observer/filing/0001193125-26-405580.md","text":"https://secwatch.observer/filing/0001193125-26-405580.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526405580/0001193125-26-405580-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526405580/vktx-20260923.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T13:38:39.130566+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}